Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Procept BioRobotics Corp shares valued at $1,597,711 were sold by Desai Antal Rohit on Jun 10 ’25. At $63.91 per share, Desai Antal Rohit sold 25,000 shares. The insider’s holdings dropped to 64,363 shares worth approximately $3.73 million following the completion of this transaction.
Also, Desai Antal Rohit sold 25,000 shares, netting a total of over 1,584,525 in proceeds. Following the sale of shares at $63.38 each, the insider now holds 39,363 shares.
Before that, Desai Antal Rohit had sold 25,000 shares from its account. In a trade valued at $1,537,256, the Director traded Procept BioRobotics Corp shares for $61.49 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $0.83 million.
As published in their initiating research note from Morgan Stanley on December 02, 2024, Procept BioRobotics Corp [PRCT] has been an Overweight and the price target has been revised to $105. Analysts at Jefferies started covering the stock with ‘”a Hold”‘ outlook in a report released in mid November. As of August 11, 2023, Piper Sandler has initiated its “an Overweight” rating for PRCT. Earlier on May 31, 2023, William Blair initiated its rating. Their recommendation was “an Outperform” for PRCT stock.
Analyzing PRCT Stock Performance
On last trading session, Procept BioRobotics Corp [NASDAQ: PRCT] plunged -0.45% to $57.92. During the last five days, there has been a drop of approximately -1.21%. Over the course of the year, Procept BioRobotics Corp shares have dropped approximately -6.38%. Shares of the company reached a 52-week high of $89.49 on 01/06/25 and a 52-week low of $47.04 on 04/07/25.
Support And Resistance Levels for Procept BioRobotics Corp (PRCT)
According to the 24-hour chart, there is a support level at 57.32, which, if violated, would cause prices to drop to 56.73. In the upper region, resistance lies at 58.76. The next price resistance is at 59.61. RSI (Relative Strength Index) is 47.28 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Procept BioRobotics Corp (PRCT)?
In terms of Procept BioRobotics Corp share price expectations, FactSet research, analysts set an average price target of 90 in the next 12 months, up nearly 54.69% from the previous closing price of $58.18. Analysts anticipate Procept BioRobotics Corp stock to reach 105 by 2025, with the lowest price target being 49. In spite of this, 2 analysts ranked Procept BioRobotics Corp stock as Buy at the end of 2025.
